Literature DB >> 29565494

Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.

K-X Lou1, Z-H Li, P Wang, Z Liu, Y Chen, X-L Wang, H-X Cui.   

Abstract

OBJECTIVE: We investigated the expression of human long non-coding ribonucleic acid (lncRNA), BRAF-activated non-coding RNA (BANCR) in breast cancer tissues and its effects on the in vitro proliferation, apoptosis, invasion and metastasis of breast cancer cells; also, we investigated its possible mechanism. PATIENTS AND METHODS: The expressions of BANCR in 65 pairs of breast cancer tissues and para-carcinoma normal breast tissues were detected by Real-time fluorescence quantitative polymerase chain reaction (qRT-PCR). The expressions of BANCR in normal breast epithelial cells (MCF10A) and breast cancer cells (MCF-7, MDA-MB-231, SKBR3 and BT-20) were further detected. The knockdown efficiency of BANCR small interfering RNA (siRNA) in MCF-7 cells was detected by qRT-PCR. The effects of BANCR knockdown on proliferation, apoptosis, invasion and metastasis capacities of MCF-7 cells were explored via methyl thiazolyl tetrazolium (MTT) proliferation assay, cell colony formation assay, fluorescence-activated cell sorting (FACS) and transwell migration assay. Western blotting was used to detect the changes in expressions of apoptosis-related proteins, epithelial-mesenchymal transition (EMT)-related proteins and matrix metalloproteinases (MMPs) after knockdown of BANCR.
RESULTS: The expression level of lncRNA BANCR in breast cancer tissues was significantly higher than that in para-carcinoma normal tissues. The prognosis of patients in low-expression BANCR group was significantly superior to that of patients in high-expression BANCR group. After BANCR knockdown in breast cancer MCF-7 cells, the cell proliferation and colony formation capacities were significantly inhibited. Further mechanism research showed that inhibiting BANCR could promote the apoptosis of MCF-7 cells. Results of Western blotting revealed that the expressions of B-cell lymphoma 2 associated X protein (BAX), cleaved-Caspase-3 and cleaved-poly adenosine diphosphate-ribose polymerase (PARP) in knockdown group were significantly up-regulated compared with those in control group. Both wound-healing assay and transwell migration assay showed that the down-regulation of lncRNA BANCR could inhibit the invasion and metastasis capacities of MCF-7 cells, whose mechanism was related to the inhibition of EMT process and down-regulation of MMP expressions in cells.
CONCLUSIONS: LncRNA BANCR is highly expressed in breast cancer, which is significantly correlated with the prognosis of patients; moreover, it can promote the growth, invasion and metastasis of ovarian cancer cells. The down-regulation of BANCR can inhibit the proliferation, invasion and metastasis capacities of MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29565494     DOI: 10.26355/eurrev_201803_14479

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

Review 1.  Emerging Role of Non-Coding RNAs in Senescence.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Aria Baniahmad; Wojciech Branicki; Mohammad Taheri; Ahmad Eghbali
Journal:  Front Cell Dev Biol       Date:  2022-07-05

Review 2.  The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis.

Authors:  Siying Zhou; Yunjie He; Sujin Yang; Jiahua Hu; Qian Zhang; Wei Chen; Hanzi Xu; Heda Zhang; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  Biosci Rep       Date:  2018-09-28       Impact factor: 3.840

Review 3.  EMT Factors and Metabolic Pathways in Cancer.

Authors:  Ilias Georgakopoulos-Soares; Dionysios V Chartoumpekis; Venetsana Kyriazopoulou; Apostolos Zaravinos
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

4.  High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis.

Authors:  Shixu Fang; Zhou Liu; Qiang Guo; Cheng Chen; Xixian Ke; Gang Xu
Journal:  BMC Cancer       Date:  2020-09-09       Impact factor: 4.430

5.  ICLRBBN: a tool for accurate prediction of potential lncRNA disease associations.

Authors:  Yuqi Wang; Hao Li; Linai Kuang; Yihong Tan; Xueyong Li; Zhen Zhang; Lei Wang
Journal:  Mol Ther Nucleic Acids       Date:  2020-12-10       Impact factor: 8.886

6.  A representation learning model based on variational inference and graph autoencoder for predicting lncRNA-disease associations.

Authors:  Zhuangwei Shi; Han Zhang; Chen Jin; Xiongwen Quan; Yanbin Yin
Journal:  BMC Bioinformatics       Date:  2021-03-21       Impact factor: 3.169

7.  Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.

Authors:  Md Motiar Rahman; Md Tofazzal Hossain; Md Selim Reza; Yin Peng; Shengzhong Feng; Yanjie Wei
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

Review 8.  The roles of long noncoding RNAs in breast cancer metastasis.

Authors:  Lingxia Liu; Yu Zhang; Jun Lu
Journal:  Cell Death Dis       Date:  2020-09-14       Impact factor: 8.469

Review 9.  Research progresses in roles of LncRNA and its relationships with breast cancer.

Authors:  Xu Bin; Yang Hongjian; Zhang Xiping; Chen Bo; Yang Shifeng; Tang Binbin
Journal:  Cancer Cell Int       Date:  2018-11-12       Impact factor: 5.722

10.  Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review.

Authors:  Stephen J O'Brien; Campbell Bishop; Jacob Hallion; Casey Fiechter; Katharina Scheurlen; Mason Paas; James Burton; Susan Galandiuk
Journal:  Cancer Biol Ther       Date:  2020-07-30       Impact factor: 4.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.